No Data
No Data
Illumina Unveils First-of-its-kind Spatial Transcriptomics Technology
NVIDIA's Rise Puts These 3 Healthcare Stocks in the Spotlight
BofA Securities Maintains Illumina(ILMN.US) With Sell Rating, Announces Target Price $90
Express News | Illumina Inc : BofA Global Research Cuts Price Objective to $90 From $110
Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference
Icahn Enterprises Increases CVR Partners, Reduces Southwest Gas, Others